Way off my normal map, but I have always assumed I would die of cancer. Now, perhaps not. New Scientist is reporting that “a cheap and simple drug that kills almost all cancers by switching off their “immortality”. The drug, dichloroacetate (DCA), has already been used for years to treat rare metabolic disorders and so is known to be relatively safe.” Best of all, no patent. Many are saying that this is a problem as it will keep drug companies from investing in R & D and trials. I say, to be known as the drug company that not only cured cancer but also made it so cheap that any person could afford it is worth many, many multiples of the $600-$700 million it would cost to bring this to market. Hey, marketing guy, how does “THE CURE” by GlaxoSmithKline sound.
-
Keith Henning
-
Newsletter
Get postings via email.
-
RSS Feeds
IP Law Journal Articles- COMMENT, Reconsidering the "Balance" of the "Digital First Sale" Debate: Re-Examing the Case for a Statutory Digital First Sale Doctrine to Facilitate Second-Hand Digital Media Markets, by Henry Sprott Long III
- NOTE, Unlocking the iPhone: How Antitrust Law Can Save Consumers from the Inadequacies of Copyright Law, by Mark DeFeo
- NOTE, Caching in on the Google Books Library Project: A Novel Approach to the Fair Use Defense and the DMCA Caching Safe Harbors, by Jesse S. Bennett
- Get Ready Cause Here They Come: A Look at Problems on the Horizon for Authorship and Termination Rights in Sound Recordings, by Abbott Marie Jones
- Locke for the Masses: Property Rights and the Products of Collective Creativity, by Robert P. Merges
-
Stats
